# A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

> **NCT06841731** · PHASE2 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Hospital-acquired Bacterial Pneumonia (HABP)
- Ventilator-associated Bacterial Pneumonia (VABP)

## Interventions

- **DRUG:** HRS-8427
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT06841731
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841731, "A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06841731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*